Diane G. Cope, PhD, APRN, BC, AOCNP Co-Authors Study on Quality of Life for Gynecologic Cancer Survivors

Ft. Myers, FL – June 24, 2019… Florida Cancer Specialists & Research Institute (FCS)  Director of Nursing, Diane G. Cope, PhD, APRN, BC, AOCNP, is co-author of an article that focuses on the results of a study whose purpose was to “describe the quality of life and needs of gynecologic cancer survivors.” Entitled “Quality of Life & Supportive Care Needs of Gynecologic Cancer Survivors,” the article was published May 12, 2019, in the Western Journal of Nursing Research, one of the top nursing research journals.

Headshot-for-Press-Release-Diane-CopeAccording to the study, “Gynecologic cancer survivors experience significant distress that can impact quality of life (QOL). Optimal survivorship care requires an understanding of the survivor’s QOL and supportive care needs.” Data collected from 34 gynecologic cancer survivors within seven months of completing treatment demonstrated that fear of a recurrence of the cancer was a major concern for survivors; other concerns that could affect QOL included “distress from diagnosis and treatment, family distress, and uncertainty about the future."

Survivors also reported that they identified several needs, which they felt could contribute to their quality of life. “Commonly reported needs included help to reduce stress, manage side effects, cope with fears of cancer recurrence, and gain reassurance that providers were communicating, and providing the very best medical care.”

Diane Cope and her co-author concluded, “Appreciating QOL and needs can facilitate the development of support services specifically tailored to gynecologic survivors."

To review an Abstract of the study:  https://journals.sagepub.com/doi/10.1177/0193945919846901

###

About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)

Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. In the past 4 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Founded in 1984, FCS is one of the largest medical oncology/hematology practices in the United States. With more than 230 physicians, 220 advanced practice registered nurses (APRN) and physician assistants (PA) and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings, close to home.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy.  Our highest values are embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.

*Prior to approval

For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer
SGlenn@FLCancer.com
(770) 365.6168

ChappellRoberts
Katy Parsons
Kparsons@ChappellRoberts.com
(813) 281.0088 ext. 327

Ganick Communications, Inc.
Elaine Ganick
Elaine@Ganick.com
(615) 377.7877